About this trial
Pelvic Sentinel Lymph Node (SLN) biopsy is an important integral part of endometrial surgery. Although SLN is usually found on internal iliac artery, location is variable. Lymphatic pathways in pelvis determines the location (Obturator, internal iliac or external iliac vessel locations). Since it is accepted that the lymphatic channel formation during embryologic life follows venous system formation investigators hypothesized that the presence or absence of superior or deep uterine vein may determine the location of sentinel lymph node
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all women with early stage endometrial cancer who will be operated for staging
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
Retroperitoneal pelvic lymphatic and uterine vessel dissection
Procedure/SurgeryICG injection to cervix uteri at 3 and 9 o'clock followed by laparoscopic dissection of retroperitoneal space to detect uterine vessels (uterine arteries, SUVs and DUVs) bilaterally in addition to detect the location and biopsy of SLN stained by ICG.
Treatment groups
Trial outcomes
Primary outcomes
Detection rate and localisation of SLN in correlation with the presence or absence of uterine veins bilaterally
The location of SLN ( obturator, external iliac and internal iliac) will be defined in percentages for each side of pelvis in relation to presence or absence of uterine vessels.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: